218 related articles for article (PubMed ID: 30379590)
41. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
Blando J; Portis M; Benavides F; Alexander A; Mills G; Dave B; Conti CJ; Kim J; Walker CL
Am J Pathol; 2009 May; 174(5):1869-79. PubMed ID: 19395652
[TBL] [Abstract][Full Text] [Related]
42. Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1.
Bhattacharyya S; Feferman L; Tobacman JK
J Biol Chem; 2015 Apr; 290(17):10764-74. PubMed ID: 25784556
[TBL] [Abstract][Full Text] [Related]
43. Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERĪ±.
Talesa VN; Ferri I; Bellezza G; Love HD; Sidoni A; Antognelli C
Prostate; 2017 Feb; 77(2):196-210. PubMed ID: 27696457
[TBL] [Abstract][Full Text] [Related]
44. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway.
He Z; Gao Y; Deng Y; Li W; Chen Y; Xing S; Zhao X; Ding J; Wang X
PLoS One; 2012; 7(4):e35926. PubMed ID: 22563417
[TBL] [Abstract][Full Text] [Related]
45. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells.
Bertram J; Peacock JW; Tan C; Mui AL; Chung SW; Gleave ME; Dedhar S; Cox ME; Ong CJ
Cancer Res; 2006 May; 66(9):4781-8. PubMed ID: 16651432
[TBL] [Abstract][Full Text] [Related]
47. Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines.
Lim HJ; Wang X; Crowe P; Goldstein D; Yang JL
Anticancer Res; 2016 Nov; 36(11):5765-5771. PubMed ID: 27793898
[TBL] [Abstract][Full Text] [Related]
48. Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.
Mao N; Gao D; Hu W; Gadal S; Hieronymus H; Wang S; Lee YS; Sullivan P; Zhang Z; Choi D; Rosen N; Sawyers CL; Gopalan A; Chen Y; Carver BS
Cancer Res; 2020 Apr; 80(7):1428-1437. PubMed ID: 32015092
[TBL] [Abstract][Full Text] [Related]
49. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
50. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
51. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
52. The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2.
Warren KJ; Fang X; Gowda NM; Thompson JJ; Heller NM
J Biol Chem; 2016 Nov; 291(48):24922-24930. PubMed ID: 27742835
[TBL] [Abstract][Full Text] [Related]
53. mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53.
Jung SH; Hwang HJ; Kang D; Park HA; Lee HC; Jeong D; Lee K; Park HJ; Ko YG; Lee JS
Oncogene; 2019 Mar; 38(10):1639-1650. PubMed ID: 30337688
[TBL] [Abstract][Full Text] [Related]
54. PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate.
Chessa TAM; Jung P; Anwar A; Suire S; Anderson KE; Barneda D; Kielkowska A; Sadiq BA; Lai IW; Felisbino S; Turnham DJ; Pearson HB; Phillips WA; Sasaki J; Sasaki T; Oxley D; Spensberger D; Segonds-Pichon A; Wilson M; Walker S; Okkenhaug H; Cosulich S; Hawkins PT; Stephens LR
Mol Cell; 2023 Aug; 83(16):2991-3009.e13. PubMed ID: 37567175
[TBL] [Abstract][Full Text] [Related]
55. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
56. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
[TBL] [Abstract][Full Text] [Related]
57. PTEN-deficient cancers depend on PIK3CB.
Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892
[TBL] [Abstract][Full Text] [Related]
58. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
Yi J; Zhu J; Wu J; Thompson CB; Jiang X
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
[TBL] [Abstract][Full Text] [Related]
59. BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway.
Yang W; Wu Z; Yang K; Han Y; Chen Y; Zhao W; Huang F; Jin Y; Jin W
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H61-H69. PubMed ID: 30359076
[TBL] [Abstract][Full Text] [Related]
60. Identification of the PTEN-ARID4B-PI3K pathway reveals the dependency on ARID4B by PTEN-deficient prostate cancer.
Wu RC; Young IC; Chen YF; Chuang ST; Toubaji A; Wu MY
Nat Commun; 2019 Sep; 10(1):4332. PubMed ID: 31551414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
